MetLife Investment Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
|
|||||
|
2025
Q1 | $50.5K | Sell |
|
|||||
|
2024
Q4 | $189K | Buy |
|
|||||
|
2024
Q3 | $58.2K | Buy |
|
|||||
|
2024
Q2 | $98.6K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $78.9K | Buy |
|
|||||
|
2022
Q4 | $138K | Hold |
|
|||||
|
2022
Q3 | $153K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $355K | Buy |
|
|||||
|
2021
Q4 | $169K | Hold |
|
|||||
|
2021
Q3 | $270K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $115K | Buy |
|